Liquidia to report Q3 2026 financial results on Nov 10 with live webcast

Liquidia Corporation, a biopharmaceutical company focused on respiratory and vascular diseases, announced it will release its third quarter 2026 financial results on November 10, 2026. The company will host a live webcast at 8:30 a.m. Eastern Time to discuss the results and provide a corporate update. Investors and interested parties can access the webcast on Liquidia’s website, with a rebroadcast available for one year. This update is important as Liquidia continues development and commercialization of treatments for pulmonary arterial hypertension and related conditions.

Liquidia Corporation is scheduled to report its third quarter 2026 financial results on November 10, 2026. On Pluang, LQDA trades at USD 41.63 with a 1-day decline of 0.53% and a market cap of $3.74 billion as of Nov 03, 2026 20:43 WIB.